Daniel S. Smith

About Daniel S. Smith

I am a global life sciences executive with 25+ years of experience leading commercial strategy, business development, and operations across pharma, biotech, bioprocessing and CDMO, GMP Compliance organizations. My career spans the full spectrum of modalities—small molecules, biologics, cell and gene therapies, sterile fill/finish, bioprocessing equipment and advanced technologies—where I’ve consistently driven revenue growth, built high-performing teams, and expanded into new markets.As a C-suite leader, I specialize in turning complex challenges into scalable solutions. From securing multi-million-dollar strategic partnerships and guiding investor readiness for biotech startups, to shaping corporate expansions in the U.S, EU, APAC, and the Kingdom of Saudi Arabia, I bring both vision and execution. I have a strong track record of P&L management, cross-functional leadership, and building long-term value through trust, collaboration, and operational excellence.Earlier in my career, I served at General Motors, Monsanto, Amgen, Samsung Biologics, Recipharm AB, ProBio and SCI FRAC Agency where I built global alliances, accelerated tech transfers, and established new market footholds that delivered sustained growth. Prior to entering life sciences, I gained invaluable leadership skills during 26 years of service with the U.S. Marine Corps, where I commanded high-performing teams and developed the operational discipline that underpins my corporate leadership style today.At every stage, my focus remains the same: advancing science, expanding access, and helping organizations thrive in highly competitive markets.Key Expertise Global Business Development & Strategic Partnerships Multi-Modality Leadership: Biologics, CGT, Sterile Fill/Finish, Small Molecules Cross-Functional Alignment & Operational Strategy Revenue Growth, P&L Ownership & Financial Stewardship Regulatory Compliance & Product Commercialization Leadership, Mentoring & High-Performance Team Building Market Expansion, Risk Mitigation & Investor Readiness

Experience

1. Chief Business & Commercial Officer Life Sciences

   Sci Frac

   Dec 2024 — Present · Cincinnati, OH, US

   Platform Leadership & Commercial Strategy: Design and execute enterprise growth strategies for external CDMOs, CROs, bioprocessing, pharma, and biotech organizations, driving expansion from early-stage buildout through commercial scale.• Lead P&L: Lead full commercial P&L design, revenue acceleration frameworks, and go-to-market transformation initiatives leveraging proprietary market intelligence platforms, driving directional top-line growth improvements of ~30% across multiple client engagements.• Revenue Infrastructure Development: Build scalable commercial operating models including pricing strategy, pipeline governance, key account management, and high-performing BD/Sales teams accelerating sales velocity by approximately 60%+ across growth-stage mandates.• Executive Team Leadership: Coach and mentor cross-functional teams (BD, Sales, Operations), including development of an 8-person execution team supporting multi-client platform engagements.• Global Market Expansion: Drive international growth across the US, EU, APAC, and Middle East, including advisory support aligned with Saudi Arabia Vision 2030 biomanufacturing initiatives.• Commercial Optimization: Implement proprietary blueprint data-driven strategies across market intelligence, competitive positioning, profitability enhancement, and margin discipline.• Capital Strategy & Fundraising Support: Develop investor-ready commercial narratives and growth roadmaps supporting Seed through Series C fundraising in collaboration with the Cincinnati Life Science Fund, a subsidiary of SCI FRAC Agency.Selected Portfolio & Strategic Contracted Partnerships• PBE Expert Inc – Fractional Chief Business Officer (Mar 2025 – Present)• Confidential Clients – Chief Commercial Officer roles within Biologics, CGT & API CDMOs / CROs | Global client locations within US, APAC, EU (Jan 2025 -Present)• Torbay Pharma UK – Fractional Chief Business Officer North America (Feb 2025)

Education

• University of La Verne

  BS, Business Administration

  1993 — 1998

• California Lutheran University

  Post-MBA - School of Business, Marketing

  2006 — 2008

• Amgen - Oncology Busness Unit University

  Oncology - Multiple Myeloma

  2016 — 2016

• Marine Corps University

  Certificate, Education and Leadership

  1996 — 1997

• University of La Verne

  MBA, Executive Management / International Business

  2000 — 2002

Skills

• Procurement
• Commitment
• Income Statement
• Market Research
• Administrative Work
• Financial Analysis
• Organizational Commitment
• Problem-Solving and Decision-Making
• Change Leadership
• Global Alliance Management
• Problem Solving
• Business Planning
• General Administration
• Strategic Alliances
• Cross-Functional Team Leadership
• Marketing Strategy
• Strategy
• Leadership
• Credit Analysis
• P&L Management
• Project Implementation
• Teamwork
• Strategic Planning
• International Business
• Sap R/3
• Supply Chain
• Sap
• Excellent Oral and Written Communication Skills
• Change Management
• Treasury
• Business Process Improvement
• Forecasting
• Taking the Initiative
• Product Management
• Profit & Loss Management
• Team Building
• Management
• Team Work
• Mircosoft
• Business Strategy